The Federal Trade Commission has given the green light to Amgen's purchase of Horizon Therapeutics.

Share:
More In Business
Cybersecurity is Entering a New Era
Jim Guinn, EY Americas Cybersecurity Leader, shares how companies must stay vigilant and navigate the evolving regulatory landscape. *Sponsored by EY
Load More